A double blind randomised placebo-controlled crossover (single centre) study in healthy men (aged 18-45 years) to investigate the effect of multiple dosing (7 days bid) of inhaled AZD4818 at different dose levels on white blood cells and inflammatory markers in induced sputum and blood after oral inhalation of lipopolysaccharide (LPS)

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].